Protalix BioTherapeutics to Announce Third Quarter 2024 Financial and Business Results on November 14, 2024PRNewsWire • Thursday
Protalix BioTherapeutics to Present Phase I PRX-115 Data in Late-Breaking Poster at ACR Convergence 2024PRNewsWire • 10/25/24
Kaskela Law LLC Announces Shareholder Investigation of Protalix BioTherapeutics, Inc. (NYSE: PLX) and Encourages Investors to Contact the FirmBusiness Wire • 09/17/24
Protalix BioTherapeutics to Present at the Life Sciences Investor Forum September 19, 2024GlobeNewsWire • 09/16/24
Protalix BioTherapeutics to Present at the H.C. Wainwright 26th Annual Global Investment ConferencePRNewsWire • 09/04/24
Protalix BioTherapeutics Announces Repayment of Outstanding Senior Secured Convertible Promissory NotesPRNewsWire • 09/03/24
Protalix BioTherapeutics Reports Second Quarter 2024 Financial and Business ResultsPRNewsWire • 08/14/24
Protalix BioTherapeutics to Announce Second Quarter 2024 Financial and Business Results on August 14, 2024PRNewsWire • 08/07/24
Protalix BioTherapeutics to Host In-Person Investor Day to Discuss Current Treatment Landscapes and Clinical Results for Fabry Disease and Uncontrolled GoutPRNewsWire • 06/13/24
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Protalix BioTherapeutics, Inc. (NYSE: PLX) and Encourages Investors to Contact the FirmAccesswire • 06/11/24
Protalix BioTherapeutics Reports First Quarter 2024 Financial and Business ResultsPRNewsWire • 05/10/24
Protalix BioTherapeutics to Announce First Quarter 2024 Financial and Business Results on May 10, 2024PRNewsWire • 05/03/24
Protalix BioTherapeutics Reports Fiscal Year 2023 Financial and Business ResultsPRNewsWire • 03/14/24
Protalix BioTherapeutics to Announce Fiscal Year 2023 Financial and Business Results on March 14, 2024PRNewsWire • 03/07/24
Protalix BioTherapeutics to Participate in the 2024 BIO CEO & Investor ConferencePRNewsWire • 02/23/24
Protalix BioTherapeutics Reports Third Quarter 2023 Financial and Business ResultsPRNewsWire • 11/06/23
Protalix BioTherapeutics to Announce Third Quarter 2023 Financial and Business Results on November 6, 2023PRNewsWire • 10/30/23
Protalix BioTherapeutics Issues Statement Regarding Security Situation in IsraelPRNewsWire • 10/09/23